Work

US Food and Drug Administration's Advancing Real‐World Evidence Program: Initial Experience

Year: 2025

Type: article

Source: Clinical Pharmacology & Therapeutics

DOI: 10.1002/cpt.3700

Authors: Kimberly A. Smith, Yin Huang, Theresa Kehoe, Stefanie Kraus, Mark Levenson, Jie Li, Kristen Miller, Ann Punnoose, Donna R. Rivera, Yueqin Zhao, Richard Forshee, John Concato

Institutions: United States Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, Yale University

Language: English

Topic: Pharmaceutical Economics and Policy

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409852861

FWCI: 3.885

Cites: 1

Cited by: 4

Related to: 10